Bristol Myers Squib & Celgene–Starboard Objections Addressed Today- Successful Deal Closure Probable
The proposed Bristol Myers Squibb Co (BMY US) & Celgene Corp (CELG US) transaction announced in the first week of 2019, garnered many sceptical...
241 Views
Facebook Inc. – Is Consensus Overly Cautious?
Facebook Inc A (FB US) is a bellwether stock for the equity markets. Although the market capitalisation is approaching $475 billion, the Company is...
593 Views
Tesla Motors – Gaining Industrial Strength
Tesla Motors (TSLA US) continues to power ahead of the competition in electric vehicles with an 80% market share of all electric vehicles sold in...
558 Views
Meituan Dianping – Is a One Billion U.S. Dollar Impairment Forthcoming?
Since initiating coverage prior to Meituan Dianping's (3690 HK) IPO, we have been bearish with respect to both its valuation and its business...
1.1k Views
Bristol Myers Squib – Reaffirming Its View on Celgene Corp
The management of Bristol Myers Squibb Co (BMY US) reiterated its optimistic view regarding the acquisition of Celgene Corp (CELG US) on its Q4-18...
547 Views